Close Menu

CIHR

The Can-Share program seeks to build policies and data tools to share data among Canadian research institutions and with international partners.

NEW YORK (GenomeWeb News) – Canada has launched a C$41 million (US$41.2 million) initiative to fund epigenetics research programs through collaborations between the Canadian Institute of Health Research (CIHR), Genome Quebec and Genome BC, the government of Japan, and the Fonds de Recherche Sante

"A key ethical question is, when you do this next-gen whole-genome sequencing, do you return that information back to the families and patients? A part of this project is to study that question," said Poul Sorensen of the BC Cancer Agency.

The C$4 million, year-long project will utilize primarily exome sequencing, and will likely focus on rare Mendelian diseases and pediatric cancers, according to officials at the Canadian Institute of Health Research and Genome Canada.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.